Baxter EBITDA Margin 2010-2025 | BAX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Baxter (BAX) over the last 10 years. The current EBITDA margin for Baxter as of March 31, 2025 is .
| Baxter EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $10.77B | $1.41B | 13.04% |
| 2024-12-31 | $10.64B | $1.49B | 13.97% |
| 2024-09-30 | $9.54B | $1.51B | 15.82% |
| 2024-06-30 | $9.44B | $1.93B | 20.41% |
| 2024-03-31 | $9.34B | $1.64B | 17.51% |
| 2023-12-31 | $10.36B | $1.69B | 16.32% |
| 2023-09-30 | $8.97B | $0.68B | 7.54% |
| 2023-06-30 | $9.98B | $0.97B | 9.75% |
| 2023-03-31 | $9.86B | $1.28B | 13.00% |
| 2022-12-31 | $10.06B | $1.38B | 13.75% |
| 2022-09-30 | $13.79B | $1.96B | 14.24% |
| 2022-06-30 | $13.40B | $2.11B | 15.77% |
| 2022-03-31 | $12.91B | $2.15B | 16.68% |
| 2021-12-31 | $12.15B | $2.22B | 18.25% |
| 2021-09-30 | $12.45B | $2.59B | 20.81% |
| 2021-06-30 | $12.20B | $2.55B | 20.91% |
| 2021-03-31 | $11.82B | $2.46B | 20.78% |
| 2020-12-31 | $11.67B | $2.46B | 21.04% |
| 2020-09-30 | $11.53B | $2.58B | 22.39% |
| 2020-06-30 | $11.41B | $2.60B | 22.80% |
| 2020-03-31 | $11.53B | $2.63B | 22.77% |
| 2019-12-31 | $11.36B | $2.59B | 22.81% |
| 2019-09-30 | $11.14B | $2.42B | 21.70% |
| 2019-06-30 | $11.05B | $2.30B | 20.82% |
| 2019-03-31 | $11.06B | $2.31B | 20.85% |
| 2018-12-31 | $11.10B | $2.36B | 21.22% |
| 2018-09-30 | $11.08B | $2.26B | 20.40% |
| 2018-06-30 | $11.02B | $2.16B | 19.62% |
| 2018-03-31 | $10.79B | $2.12B | 19.61% |
| 2017-12-31 | $10.58B | $2.04B | 19.26% |
| 2017-09-30 | $10.43B | $2.07B | 19.80% |
| 2017-06-30 | $10.28B | $1.97B | 19.18% |
| 2017-03-31 | $10.26B | $1.72B | 16.71% |
| 2016-12-31 | $10.16B | $1.55B | 15.20% |
| 2016-09-30 | $10.12B | $1.39B | 13.68% |
| 2016-06-30 | $10.05B | $1.30B | 12.97% |
| 2016-03-31 | $9.94B | $1.31B | 13.14% |
| 2015-12-31 | $9.97B | $1.21B | 12.12% |
| 2015-09-30 | $10.15B | $1.26B | 12.36% |
| 2015-06-30 | $10.38B | $1.27B | 12.21% |
| 2015-03-31 | $12.06B | $1.90B | 15.78% |
| 2014-12-31 | $13.50B | $2.53B | 18.75% |
| 2014-09-30 | $15.03B | $2.75B | 18.28% |
| 2014-06-30 | $16.03B | $3.29B | 20.51% |
| 2014-03-31 | $15.55B | $3.39B | 21.79% |
| 2013-12-31 | $15.15B | $3.38B | 22.30% |
| 2013-09-30 | $14.33B | $3.47B | 24.23% |
| 2013-06-30 | $14.09B | $3.57B | 25.30% |
| 2013-03-31 | $14.00B | $3.51B | 25.09% |
| 2012-12-31 | $13.94B | $3.48B | 24.99% |
| 2012-09-30 | $14.03B | $3.57B | 25.47% |
| 2012-06-30 | $14.03B | $3.54B | 25.21% |
| 2012-03-31 | $14.00B | $3.58B | 25.58% |
| 2011-12-31 | $13.89B | $3.62B | 26.03% |
| 2011-09-30 | $13.80B | $3.53B | 25.56% |
| 2011-06-30 | $13.54B | $3.56B | 26.27% |
| 2011-03-31 | $13.20B | $3.43B | 25.95% |
| 2010-12-31 | $12.84B | $2.82B | 21.97% |
| 2010-09-30 | $12.82B | $3.02B | 23.60% |
| 2010-06-30 | $12.74B | $2.97B | 23.30% |
| 2010-03-31 | $12.67B | $3.00B | 23.70% |
| 2009-12-31 | $12.56B | $3.52B | 27.98% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.380B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.329B | 27.82 |
| Boston Scientific (BSX) | United States | $151.540B | 37.94 |
| Stryker (SYK) | United States | $146.015B | 30.53 |
| EssilorLuxottica (ESLOY) | France | $127.709B | 0.00 |
| Medtronic (MDT) | Ireland | $109.786B | 15.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.554B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.214B | 28.03 |
| ResMed (RMD) | United States | $36.648B | 27.53 |
| Agilent Technologies (A) | United States | $32.650B | 21.28 |
| GE HealthCare Technologies (GEHC) | United States | $32.569B | 15.46 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.464B | 88.18 |
| Koninklijke Philips (PHG) | Netherlands | $21.600B | 15.53 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.819B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.043B | 21.03 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.190B | 18.72 |
| Perrigo (PRGO) | Ireland | $3.610B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.233B | 23.84 |
| Envista Holdings (NVST) | United States | $3.178B | 26.41 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.102B | 14.46 |
| LeMaitre Vascular (LMAT) | United States | $1.865B | 41.69 |
| AtriCure (ATRC) | United States | $1.729B | 0.00 |
| Acuren (TIC) | United States | $1.228B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.101B | 24.76 |
| Neogen (NEOG) | United States | $1.077B | 13.78 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.016B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.972B | 12.42 |
| InMode (INMD) | Israel | $0.931B | 9.38 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.571B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.564B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Owens & Minor (OMI) | United States | $0.515B | 4.27 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.412B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 12.52 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.313B | 55.70 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.61 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 52.30 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.56 |
| TerrAscend (TSNDF) | Canada | $0.089B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.035B | 47.43 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |